Clinical Trial Update: Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia [NA]

View source ↗

Summary

This clinical trial update reports on low-dose rituximab regimens in Chinese adults with immune thrombocytopenia and notes the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Immune Thrombocytopenic Purpura | NA | Status: COMPLETED